Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer | Warsaw | Healthcare | Pharmaceuticals | PLN 86.40B | -22.6x | 0.1 | PLN 88.43 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Krka, d. d. | Warsaw | Healthcare | Pharmaceuticals | PLN 18.44B | 13.2x | 0.49 | PLN 604 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neuca SA | Warsaw | Healthcare | Pharmaceuticals | PLN 3.47B | 20.8x | 0.41 | PLN 776 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.2% Upside | Upgrade to Pro+ | |
Celon Pharma | Warsaw | Healthcare | Pharmaceuticals | PLN 1.37B | -28.8x | 0.62 | PLN 25.75 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.5% Upside | Upgrade to Pro+ | |
Bioceltix | Warsaw | Healthcare | Pharmaceuticals | PLN 377.21M | -19.5x | 2.08 | PLN 73.40 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.6% Upside | Upgrade to Pro+ | |
Synthaverse | Warsaw | Healthcare | Pharmaceuticals | PLN 309.90M | 126.6x | -1.76 | PLN 4.41 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cosma | Warsaw | Healthcare | Pharmaceuticals | PLN 66.09M | -2.7x | 0.01 | PLN 0.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biomaxima | Warsaw | Healthcare | Pharmaceuticals | PLN 59.54M | -132.7x | 1.08 | PLN 14 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biogened | Warsaw | Healthcare | Pharmaceuticals | PLN 55.02M | 10.3x | 0.23 | PLN 22.40 | -13.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cannabis Poland SA | Warsaw | Healthcare | Pharmaceuticals | PLN 23.42M | -15.6x | 1.28 | PLN 0.48 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genxone | Warsaw | Healthcare | Pharmaceuticals | PLN 23.07M | -5.6x | 0.19 | PLN 6.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |